Vanda Pharmaceuticals (VNDA) Operating Leases (2019 - 2025)
Historic Operating Leases for Vanda Pharmaceuticals (VNDA) over the last 7 years, with Q3 2025 value amounting to $3.4 million.
- Vanda Pharmaceuticals' Operating Leases fell 3767.77% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 3767.77%. This contributed to the annual value of $4.9 million for FY2024, which is 4742.66% down from last year.
- According to the latest figures from Q3 2025, Vanda Pharmaceuticals' Operating Leases is $3.4 million, which was down 3767.77% from $3.9 million recorded in Q2 2025.
- Vanda Pharmaceuticals' 5-year Operating Leases high stood at $12.4 million for Q4 2021, and its period low was $3.4 million during Q3 2025.
- Its 5-year average for Operating Leases is $8.0 million, with a median of $8.4 million in 2023.
- As far as peak fluctuations go, Vanda Pharmaceuticals' Operating Leases crashed by 835.32% in 2021, and later tumbled by 4742.66% in 2024.
- Over the past 5 years, Vanda Pharmaceuticals' Operating Leases (Quarter) stood at $12.4 million in 2021, then fell by 9.91% to $11.1 million in 2022, then fell by 15.59% to $9.4 million in 2023, then plummeted by 47.43% to $4.9 million in 2024, then plummeted by 30.85% to $3.4 million in 2025.
- Its last three reported values are $3.4 million in Q3 2025, $3.9 million for Q2 2025, and $4.4 million during Q1 2025.